Focus on: magnetic resonance-based studies of fetal alcohol spectrum disorders in animal models.
Fetal alcohol syndrome (Research)
Fetal alcohol syndrome (Diagnosis)
Magnetic resonance imaging (Usage)
Fetus (Effect of alcohol on)
O'Leary-Moore, Shonagh K.
Parnell, Scott E.
Godin, Elizabeth A.
Sulik, Kathleen K.
|Publication:||Name: Alcohol Research & Health Publisher: U.S. Government Printing Office Audience: Academic; Professional Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2011 U.S. Government Printing Office ISSN: 1535-7414|
|Issue:||Date: Spring, 2011 Source Volume: 34 Source Issue: 1|
|Topic:||Event Code: 310 Science & research|
|Geographic:||Geographic Scope: United States Geographic Code: 1USA United States|
Animal studies using magnetic resonance (MR)-based imaging
technologies, including MR imaging (MRI), diffusion tensor imaging
(DTI), and MR spectroscopy (MRS) provide important insight into
alcohol's early effects on the fetal brain. This article reviews
how these valuable tools have been applied to the study of fetal alcohol
spectrum disorders (FASD) in animal models. Compared with clinical
studies of the effects of alcohol on development, using animal models
allows greater control over dose, duration, and pattern of alcohol
exposure. For example, research examining the effects of alcohol at
different developmental stages and at various doses has helped highlight
the vulnerability of the prenatal brain to very early alcohol-mediated
damage. This research has important implications for clinical practice
and ongoing research.
MRI is a noninvasive imaging technique that relies on powerful magnetic fields, radiofrequency pulses, and computer analysis to produce detailed pictures of organs, soft tissues, bone, and virtually all other internal body structures. This is in contrast to other imaging techniques that use ionizing radiation (e.g., X-rays). The application of MRI to the study of small animals has been facilitated by the development and availability of high--field strength MR systems (7 to 14 Tesla); custom radiofrequency coils (i.e., coils made specifically for imaging small animals); and the use of active-staining contrast agents, which are used to enhance the contrast of structures being viewed (reviewed by Petiet et al. 2007; Turnbull and Mori 2007). Advances in technology have allowed researchers to generate MR images with high spatial resolution, which is the ability to distinguish between two points, and sufficient contrast to allow delineation of the brain structures beneath the cerebral cortex, even in fetal mice (Petiet et al. 2008). The generation of MR scans that are isotropic (i.e., the volume elements [voxels] are uniform in all directions) allows these high-resolution images to be readily realigned and visualized in all planes simultaneously, thus facilitating accurate segmentation, three-dimensional reconstruction, and volumetric assessments of selected brain regions (see figure 1). It currently takes 2 to 3 hours to acquire high-resolution isotropic images of a mouse fetus, though technological advances promise to greatly reduce the amount of time (and expense) required.
STUDIES OF ALCOHOL-INDUCED DAMAGE
In addition to providing a broad perspective on normal development, MRI also has tremendous potential to aid in explaining abnormal tissue formation. To date, in the few published reports describing MRI-based analyses of alcohol-induced defects in animal models, the brain has been the region most studied (Astley et al. 1995; Godin et al. 2010; Miller et al. 1999; Parnell et al. 2009). Future application of this technology to the study of alcohol's effects on abnormal development in other organ systems (e.g., the heart and kidney) is also promising (e.g., Petiet et al. 2008).
Applying high-resolution MRI (also known as MR microscopy) to an established mouse FASD model, the authors have initiated a series of investigations aimed at identifying dose- and developmental stage--dependent patterns of alcohol-induced abnormalities. With the goal of identifying both mild and severe structural brain defects, and recognizing that defects at the severe end of the spectrum may not be compatible with postnatal viability in mice, the researchers selected a late prenatal stage (i.e., gestational day [GD] 17) for initial end point analyses. To date, results have been published from MRI-based analysis of defects following acute high-dose alcohol exposure (i.e., peak blood alcohol concentrations ranging from 350 to 440 mg/dl or 0.35 to 0.40 percent) on GD 7 and GD 8 (corresponding, respectively, to late in week 3 and early in week 4 of human prenatal development) (Godin et al. 2010; Parnell et al. 2009).
GD 7 alcohol exposure was shown to cause a variety of brain and facial defects that are notable on GD 17. Consistent with previous reports (reviewed by Sulik 2005; Sulik and Johnston 1982; Sulik et al. 1984), a subset of the brain defects that result from this early alcohol exposure fall within the spectrum of holoprosencephaly (HPE), a disorder characterized by abnormal median union of the right and left cerebral hemispheres and reduction in median forebrain tissues including the corpus callosum, which connects the left and right hemispheres. At the severe end of the spectrum, the tissue deficiency involves the olfactory bulbs, which may be small or absent. As shown in figure 2, three-dimensional MRI reconstructions clearly show these abnormalities in fetal mice. Additionally, as shown in this figure, MRI scans can be reconstructed to provide three-dimensional views of the facial surfaces. The facial defects caused by GD 7 alcohol exposure include abnormally close positioning of the nostrils and a long (from nose to mouth) upper lip. These facial features are consistent with those that occur in individuals with fetal alcohol syndrome (FAS). In FAS, forebrain deficiencies are a well-recognized feature, and anomalies in the corpus callosum are particularly pronounced (reviewed by Norman et al. 2009). In fact, a recent MRI study illustrated that in mice, GD 7 alcohol exposure--induced median forebrain defects also are present postnatally. As shown in figure 3, MRIs of adolescent mice prenatally exposed to alcohol show deficiencies in the corpus callosum, similar to those seen in MRIs of individuals with FAS (Mattson et al. 1994).
[FIGURE 1 OMITTED]
In addition to illustrating median facial and brain deficiencies, high-resolution MRI in fetal mice facilitated the discovery of cells in the cerebral cortex that are misplaced from their intended location as a result of GD 7 alcohol exposure (Godin et al. 2010) (see figure 4). These aberrant tissue masses (i.e., heterotopias) were first noted upon examination of three-dimensional brain reconstructions. Because MRI methodologies allow the brain tissue to remain intact, routine microscopic analysis of tissue slices (i.e., histological analysis) can be performed after imaging (see figure 4B). This histological analysis of the affected brain areas illustrated the typical features of heterotopias associated with the thin tissues covering the brain (i.e., leptomeningeal heterotopias) and allowed their classification as such. Prenatal alcohol exposure has previously been associated with heterotopias in both animal models and people with FAS (e.g., Coulter et al. 1993; Komatsu et al. 2001). The finding that alcohol-mediated damage occurring during a narrow window of very early development can result in these cerebral cortical defects is both remarkable and of significant clinical importance. Heterotopias are highly correlated with seizure disorders, and a number of human and animal studies point to prenatal alcohol exposure as a risk factor for seizure susceptibility (e.g., Bonthius et al. 2001; Sun et al. 2009).
[FIGURE 2 OMITTED]
Although not as "comprehensive" as volumetric analyses, linear measures are readily made from individual MRI scans (see figure 1) and also are useful for detecting patterns of effects following discrete periods of alcohol exposure. This is exemplified by the finding of reduced frontothalamic and brain-width measures in fetal mice following GD 7 alcohol exposure (Godin et al. 2010), whereas GD 8 alcohol exposure was found to reduce transverse cerebellar diameter and to increase third-ventricle widths (Parnell et al. 2009). These data confirm and extend findings from human prenatal ultrasound studies (Kfir et al. 2009) and enhance the potential for prenatal FASD diagnosis.
[FIGURE 3 OMITTED]
DTI, an MRI technique that holds additional promise for elucidating alcohol's adverse effects on central nervous system (CNS) development, allows visualization of the pattern and integrity of CNS fiber tracts and is based on identifying the rate and direction of water diffusion through the tissue. This technique capitalizes on the fact that diffusion is more isotropic in cerebral spinal fluid and cell bodies but greater in one direction than the others (i.e., anisotropic) along the projections of nerve cells (i.e., axons) that comprise fiber tracts. Even in the absence of gross structural brain malformations, DTI can detect microstructural changes within the fiber tracts.
Researchers have reported a number of DTI studies of rodent brains (reviewed by Mori and Zhang 2006). Imaging mouse fetuses as young as GD 12, Zhang and colleagues (2003) showed that even before axons develop their insulating myelin sheaths, fiber orientation within the developing brain can be identified using DTI. The fiber orientation data can be depicted in color-coded maps, examples of which are shown in images of a control and alcohol-exposed GD 17 mouse brain in figures 5A and 5B, respectively. In these images, the red, blue, and green colors indicate fibers running in left/right, inferior/ superior, and anterior/posterior directions, respectively. Among the fiber tracts that are evident in the normal fetal brain are the corpus callosum; the fimbria, a band of white matter along the edge of the hippocampus; the fornix, a bundle of fibers that connects the hippocampus on either side of the brain and then projects down and back toward the thalamus; and the fasciculus retroflexus, which consists of major output fibers of the forebrain. DTI data also can be depicted by using specialized processing software to render three-dimensional reconstructions of the fiber tracts, examples of which are shown for the fimbria/ fornix of a GD 17 control and alcohol-exposed fetus in figures 5C and 5D, respectively.
[FIGURE 4 OMITTED]
In the FASD research arena, DTI has been applied to define white-matter anomalies in the human whole brain (e.g., Fryer 2009; Lebel et al. 2008, 2010; Sowell et al. 2008). The majority of these studies have focused primarily on examination of the corpus callosum. In both children and young adults who were prenatally exposed to alcohol, researchers have reported alterations in measures of diffusivity involving this major fiber tract (e.g., Fryer et al. 2009; Lebel et al. 2008, 2010; Li et al. 2009; Ma et al. 2005; Sowell et al. 2008; Wozniak et al. 2006, 2009). O'Leary-Moore and colleagues (2010) currently are using DTI in animals to extend the MRI-based FASD studies described above. Following GD 7 alcohol exposure, the researchers have found deficits in a number of major fiber tracts including the corpus callosum and fimbria/fornix in their mouse model (see figure 5B and D). It is anticipated that these ongoing ex vivo DTI studies will yield a wealth of information and that technological advances will reduce the time required for small-animal imaging and provide the potential to extend the analyses to live specimens.
MRS is a technique that allows the noninvasive assessment of a number of neurochemicals in the brain and detection of subtle changes in brain biochemistry in the absence of gross dysmorphology. Based on the same principles as MRI, MRS suppresses water signals (which typically are exploited in anatomical imaging) and provides the ability to assess neurochemicals in localized regions of the brain (Moore and Galloway 2002). It appears that MRS-based neurochemical data may be useful as a biomarker for prenatal alcohol exposure.
Among the neurochemicals that can be measured using MRS, the three most readily assessed are ^-acetyl-aspartate (NAA), a marker of neuronal integrity that is reduced in a myriad of disease states; choline, an essential nutrient necessary for the synthesis of acetylcholine and the cell membrane constituent phosphatidylcholine; and creatine, a high-energy phosphate important in maintaining cellular energy--dependent systems. Studies in humans and nonhuman primates have shown changes in each of these neurochemicals following prenatal alcohol exposure (Astley et al. 1995, 2009; Cortese et al. 2006; Fagerlund et al. 2006). However, the direction of change and the brain region dependency of these effects have varied, possibly as a result of different stages of development of the subjects at the time of analysis and variations in alcohol dose and exposure times between study groups (Astley et al. 2009; Cortese et al. 2006; Fagerlund et al. 2006). Other neurochemicals also are clinically identifiable, but they are less frequently reported and often require the use of higher-field-strength magnets (4 Tesla) or specialized techniques for their measurement and quantification (Moore and Galloway 2002).
[FIGURE 5 OMITTED]
Facilitated by the availability of high-resolution MRS techniques such as high-resolution magic-angle spinning (HR-MAS) MRS, researchers have initiated MRS-based analyses employing rodent FASD models to elucidate developmental stage--and region-dependent neurochemical changes. HR-MAS MRS provides neurochemical information from intact ex vivo tissue punches from multiple localized brain regions and allows the assessment of more neurochemicals than is possible using conventional MRS in clinical populations. Figure 6 shows a typical HR-MAS MRS neurochemical spectrum. Here, each neurochemical is identified by its unique chemical shift position on the horizontal axis. The concentration of each neurochemical is proportional to the area under its respective peak(s). Applying this technique, O'Leary-Moore and colleagues (2008) showed that neonatal alcohol exposure in rats (at a time corresponding to the human third trimester) significantly reduced levels of NAA and taurine (an inhibitory neuromodulator and antioxidant) in the cerebellum and striatum; elevated levels of myo-inositol, a marker for neuronal support cells (i.e., glial cells) in the cerebellum; and, in females, reduced cerebellar glutamate levels. The lowered NAA and glutamate levels may indicate that significant cell loss occurred as a result of the alcohol exposure. This is consistent with previously reported cerebellar cell number reductions resulting from alcohol exposure during the neonatal period (reviewed by Green 2004). Whether these reductions in number are directly related to diminished antioxidant capacity, as indicated by low taurine levels, remains to be determined. In this regard, it is notable that a number of studies have shown the potential of antioxidants to reduce alcohol's disruptive effects on development (reviewed by Cohen-Kerem and Koren 2003).
[FIGURE 6 OMITTED]
The continued application of MR-based technologies to the study of FASD in animal models promises to greatly facilitate the definition of the full spectrum of alcohol-induced birth defects along with their developmental stage and dosage dependency. Recognition of the entire range of consequences is essential for accurate diagnosis and prevention. With respect to the latter, MRI-based rodent studies have highlighted the vulnerability of the brain to alcohol-mediated damage resulting from alcohol exposure at developmental stages that occur in humans prior to the time that pregnancy is typically recognized, underscoring the importance of pre-pregnancy counseling. In addition to the ex vivo analyses that have been conducted to date, evolving MRI technologies are expected to allow longitudinal studies of both the brain and behavior in individual animals. Overall, these MR-based animal studies are expected to provide data that will inform clinical practice and ongoing research.
This work was supported by NIH/NIAAA grants RC1AA--019211, T32AA--007573, P60AA--11605, and U01AA--017124; National Center for Research Resources/ National Cancer Institute grants P41--05959 and U24--CA092656; and the University of North Carolina Neurodevelopmental Disorders Research Center grant HD 03110.
This study was conducted in conjunction with the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD). Additional information about CIFASD can be found at www.cifasd.org.
The authors declare that they have no competing financial interests.
ASTLEY, S.J.; RICHARDS, T.; AYLWARD, E.H.; ET AL. Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. Magnetic Resonance Imaging 27(6): 760-778, 2009. PMID: 19342189
ASTLEY, S.J.; WEINBERGER, E.; SHAW, D.W.; ET AL. Magnetic resonance imaging and spectroscopy in fetal ethanol exposed Macaca nemestrina. Neurotoxicology and Teratology 17(5):523-530, 1995. PMID: 8551998
BONTHIUS, D.J.; WOODHOUSE, J.; BONTHIUS, N.E.; ET AL. Reduced seizure threshold and hippocampal cell loss in rats exposed to alcohol during the brain growth spurt. Alcoholism: Clinical and Experimental Research 25(1):70-82, 2001. PMID: 11198717
COHEN-KEREM, R., AND KOREN, G. Antioxidants and fetal protection against ethanol teratogenicity: I. Review of experimental data and implications to humans. Neurotoxicology and Teratology 25(1): 1-9, 2003. PMID: 12633732
CORTESE, B.M.; MOORE, G.J.; BAILEY, B.A.; ET AL. Magnetic resonance and spectroscopic imaging in prenatal alcohol-exposed children: Preliminary findings in the caudate nucleus. Neurotoxicology and Teratology 28(5):597-606, 2006. PMID: 16996247
COULTER, C.L.; LEECH, R.W.; SCHAEFER, G.B.; ET AL. Midline cerebral dysgenesis, dysfunction of the hypothalamic-pituitary axis, and fetal alcohol effects. Archives of Neurology 50(7):771-775, 1993. PMID: 8323485
FAGERLUND, A.; HEIKKINSEN, S.; AUTTI-RAMO, I.; ET AL. Brain metabolic alterations in adolescents and young adults with fetal alcohol spectrum disorders. Alcoholism: Clinical and Experimental Research, 30(12): 2097-2104, 2006. PMID: 17117975
FRYER, S.L.; SCHWEINSBURG, B.C.; BJORKQUIST, O.A.; ET AL. Characterization of white matter microstructure in fetal alcohol spectrum disorders. Alcoholism: Clinical and Experimental Research 33(3):514-512, 2009. PMID: 19120066
GODIN, E.A.; O'LEARY-MOORE, S.K.; KHAN, A.A.; ET AL. Magnetic resonance microscopy defines ethanol-induced brain abnormalities in prenatal mice: Effects of acute insult on gestational day 7. Alcoholism: Clinical and Experimental Research 34(1):98-111, 2010. PMID: 19860813
GREEN, J.T. The effects of ethanol on the developing cerebellum and eyeblink classical conditioning. Cerebellum 3(3):178-187, 2004. PMID: 15543808
KFIR, M.; YEVTUSHOK, L.; ONISHCHENKO, S.; ET AL. Can prenatal ultrasound detect the effects of in-utero alcohol exposure? A pilot study. Ultrasound in Obstetrics & Gynecology 33(6):683-689, 2009. PMID: 19444822
KOMATSU, S.; SAKATA-HAGA, H.; SAWADA, K.; ET AL. Prenatal exposure to ethanol induces leptomeningeal heterotopia in the cerebral cortex of the rat fetus. Acta Neuropathologica 101(1):22-26, 2001. PMID: 11194937
LEBEL, C.; RASMUSSEN, C.; WYPER, K.; ET AL. Brain diffusion abnormalities in children with fetal alcohol spectrum disorder. Alcoholism: Clinical and Experimental Research 32(10):1732-1740, 2008. PMID: 18671811
LEBEL, C.; RASMUSSEN, C.; WYPER, K.; ET AL. Brain microstructure is related to math ability in children with fetal alcohol spectrum disorder. Alcoholism: Clinical and Experimental Research 34(2):354-363, 2010. PMID: 19930234
LI, L.; COLES, C.D.; LYNCH, M.E.; AND HU, X. Voxelwise and skeleton-based region of interest analysis of fetal alcohol syndrome and fetal alcohol spectrum disorders in young adults. Human Brain Mapping30(10):3265-3274, 2009. PMID: 19278010
MA, X.; COLES, C.D.; LYNCH, M.E.; ET AL. Evaluation of corpus callosum anisotropy in young adults with fetal alcohol syndrome according to diffusion tensor imaging. Alcoholism: Clinical and Experimental Research 29(7):1214-1222, 2005. PMID: 16046877
MATTSON, S.S.; JERNIGAN, T.L.; AND RILEY, E.P. MRI and prenatal alcohol exposure. Alcohol Health & Research World 19(4):49-52, 1994.
MILLER, M.W.; ASTLEY, S.J.; and Clarren, S.K Number of axons in the corpus callosum of the mature Macaca nemestrina Increases caused by prenatal exposure to ethanol. Journal of Comparative Neurology 412(1): 123-131, 1999. PMID: 10440714
MOORE, G.J., AND GALLOWAY, M.P. Magnetic resonance spectroscopy: Neurochemistry and treatment effects in affective disorders. Psychopharmacology Bulletin 36(2):5-23, 2002. PMID: 12397837
MORI, S., AND ZHANG, J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51(5):527-539, 2006. PMID: 16950152
O'LEARY-MOORE, S.K.; MCMECHAN, A.P.; GALLOWAY, M.P.; AND HANNIGAN, J.H. Neonatal alcohol-induced region-dependent changes in rat brain neurochemistry as measured by high-resolution magnetic resonance spectroscopy. Alcoholism: Clinical and Experimental Research 32(10): 1697-1707, 2008. PMID: 18631322
O'LEARY-MOORE, S.K.; PARNELL, S.E.; GODIN, E.A; ET AL. Magnetic resonance microscopy and diffusion tensor imaging define stage-dependent changes in brain morphology after prenatal ethanol exposure in mice. Alcoholism: Clinical and Experimental Research 32(6) (Suppl. 2):98A, 2008.
PARNELL, S.E.; O'LEARY-MOORE, S.K.; GODIN, E.A.; ET AL. Magnetic resonance microscopy defines ethanol-induced brain abnormalities in prenatal mice: Effects of acute insult on gestational day 8. Alcoholism: Clinical and Experimental Research 33(6):1001-1011, 2009. PMID: 19302087
PETIET, A.; HEDLUND, L.; AND JOHNSON, G.A. Staining methods for magnetic resonance microscopy of the rat fetus. Journal of Magnetic Resonance Imaging 25(6):1192-1198, 2007. PMID: 17520739
PETIET, A.E.; KAUFMAN, M.H.; GODDEERIS, M.M.; ET AL. High-resolution magnetic resonance histology of the embryonic and neonatal mouse: A 4D atlas and morphological database. Proceedings of the National Academy of Sciences of the United States of America 105(34):12331-12336, 2008. PMID: 18713865
SULIK, K.K. Genesis of alcohol-induced craniofacial dysmorphism. Experimental Biology and Medicine (Maywood) 230(6):366-375, 2005. PMID: 15956766
SULIK, K.K., AND JOHNSTON, M.C. Embryonic origin of holoprosencephaly: Interrelationship of the developing brain and face. Scanning Electron Microscopy (Pt 1):309-322, 1982. PMID: 7167750
SULIK, K.K.; LAUDER, J.M.; AND DEHART, D.B. Brain malformations in prenatal mice following acute maternal ethanol administration. International Journal of Developmental Neuroscience 2(3):203-214, 1984.
SUN, Y.; STRANDBERG-LARSEN, K.; VESTERGAARD, M.; ET AL. Binge drinking during pregnancy and risk of seizures in childhood: A study based on the Danish National Birth Cohort. American Journal of Epidemiology 169(3): 313-322, 2009. PMID: 19064645
TOBIN, J.L.; DIFRANCO, M.; ELCHERS, E.; ET al. Inhibition of neural crest migration underlies craniofacial dysmorphology and Hirschsprung's disease in Bardet-Biedl syndrome. Proceedings of the National Academy of Sciences of the United States of America 105(18):6714-6719, 2008. PMID: 18443298
TURNBULL, D.H., AND MORI, S. MRI in mouse developmental biology. NMR in Biomedicine 20(3):265-274, 2007. PMID: 17451170
WOZNIAK, J.R.; MUELLER, B.A.; CHANG, P.N.; ET AL. Diffusion tensor imaging in children with fetal alcohol spectrum disorders. Alcoholism: Clinical and Experimental Research 30(10):1799-1806, 2006. PMID: 17010147
WOZNIAK, J.R.; MUETZEL, R.L.; Mueller, B.A.; ET AL. Microstructural corpus callosum anomalies in children with prenatal alcohol exposure: An extension of previous diffusion tensor imaging findings. Alcoholism: Clinical and Experimental Research 33(10):1825-1835, 2009. PMID: 19645729
ZHANG, J., RICHARDS, L.J., YAROWSKY, P., ET AL. Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging. NeuroImage 20(3):1639-1648, 2003. PMID: 14642474
SHONAGH K. O'LEARY-MOORE, PH.D., is a postdoctoral fellow; SCOTT E. PARNELL, PH.D., is a research assistant professor; ELIZABETH A. GODIN, PH.D., is a former graduate student in toxicology; and KATHLEEN K. SULIK, PH.D., is a professor in the Department of Cell and Developmental Biology and all are affiliated with the Bowles Center for Alcohol Studies, University of North Carolina, Chapel Hill, North Carolina.
|Gale Copyright:||Copyright 2011 Gale, Cengage Learning. All rights reserved.|